Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 26 2021

Ductal Carcinoma In Situ (DCIS)

Images
https://upload.medbullets.com/topic/120425/images/dcis.jpg
https://upload.medbullets.com/topic/120425/images/dcis.jpg
https://upload.medbullets.com/topic/120425/images/dcis_mammo..jpg
https://upload.medbullets.com/topic/120425/images/dcis_histo.jpg
  • Snapshot
    • A 58-year-old woman presented to her primary care physician after a screening mammogram revealed calcifications in the left breast. Physical exam revealed no palpable breast lumps or axillary lymphadenopathy.
  • Introduction
    • Overview
      • a neoplastic lesion confined to the breast duct
      • a true premalignancy
        • 50% develop into invasive ductal carcinoma if untreated
          • risk is for both the ipsilateral and contralateral breast
  • Epidemiology
    • Incidence
      • 32.5 in 100,000 women
      • represents ~20% of breast cancer diagnoses in the U.S.
    • Risk factors
      • increasing age
      • nulliparity
      • family history of breast cancer
      • age ≥ 30 or older at birth of first child
      • obesity
  • ETIOLOGY
    • Genetics
      • inheritance
        • increased risk with BRCA1 and BRCA2 mutations
      • mutations
        • 75% of DCIS is estrogen (ER)/progesterone (PR) receptor-positive
    • Associated conditions
      • Paget disease of the breast
        • overlying breast skin changes that may occur in association with DCIS
          • skin crusting and itching
  • Presentation
    • Symptoms
      • asymptomatic
    • Presentation
      • typically no palpable mass on exam
      • +/- nipple discharge
      • +/- overlying breast skin crusting
  • Imaging
    • Mammography
      • indications
        • screening
          • DCIS often detected on screening mammogram
      • findings
        • calcifications
          • in 90% of DCIS
          • linear calcifications associated with more aggressive DCIS
          • granular calcifications associated with less aggresive DCIS
        • breast mass
          • uncommon but occassionally found on mammography (~8% of cases)
    • Ultrasound
      • indications
        • to guide biopsy if lesion is visible on US
      • findings
        • microlobulated mild hypoechoic mass with ductal extension
    • Core or excisional biopsy
      • indications
        • diagnosis following detection of calcifications on mammogram
          • using stereotactic guidance
      • findings
        • proliferation of neoplastic cells within the mammary ductal system
        • 11% will have findings of microinvasion
  • Differential
    • Lobular carcinoma in situ (LCIS)
      • key distinguishing factor
        • e-cadherin expression on histology
          • positive in DCIS and negative in LCIS
    • Invasive carcinoma
      • key distinguishing factor
        • evidence of invasion on biopsy
  • Treatment
    • Medical
      • radiation
        • indications
          • postoperative following lumpectomy
      • endocrine therapy
        • indications
          • ER/PR-positive DCIS to reduce chance of developing invasive cancer
            • especially in patients who did not undergo bilateral mastectomy
        • modalities
          • tamoxifen
      • close follow-up and screening mammography
        • indications
          • all DCIS patients to detect future development of invasive carcinoma
    • Surgical
      • lumpectomy
        • indications
          • relatively smaller masses compared to size of breast
          • ability to get negative margins
            • multicentric disease involving more than one quadrant is a relative contraindication
        • followed by radiation
          • can skip radiation if low-grade DCIS that is < 1-2 cm
      • mastectomy (typically bilateral)
        • indications
          • invasive components on biopsy
          • multicentric disease
          • relatively large masses compared to size of breast
          • patients who prefer bilateral mastectomy in order to reduce risk of future invasive carcinoma
  • Complications
    • Development of invasive carcinoma
      • ~6% risk of recurrence of invasive carcinoma after DCIS treatment in both contralateral and ipsilateral breast
    • Death
  • Prognosis
    • Excellent
      • ~1.7-3% mortality in treated patients
Card
1 of 0
Question
1 of 1
Private Note